News

Article

Pharmaceutical Technology

Pharmaceutical Technology, Regulatory Sourcebook, March 2022
Volume2022 eBook
Issue 1
Pages: 52-54

Facilitating Biopharma Continuous Manufacturing

Author(s):

Jennifer Markarian

USP is advancing understanding and developing guidance and standards to assist industry in implementing continuous manufacturing.

Rawpixel.com/Stock.adobe.com

Rawpixel.com/Stock.adobe.com

Manufacturers, regulators, and other industry organizations are aiming to advance biopharmaceutical continuous manufacturing and to connect upstream and downstream into fully continuous processes. The United States Pharmacopeial Convention (USP), a nonprofit organization known for developing standards for quality, is actively involved in facilitating implementation of continuous manufacturing in the bio/pharmaceutical industry. Pharmaceutical Technology spoke with John Kokai-Kun, director, External Scientific Collaboration at USP about these efforts.

Read “Facilitating Biopharma Continuous Manufacturing” in Pharmaceutical Technology’s Quality and Regulatory Sourcebook Ebook.

Article details:

Pharmaceutical Technology
eBook: Quality and Regulatory Sourcebook
March 2022
Pages: 52-54

Citation

When referring to this article, please cite it as J. Markarian, “Facilitating Biopharma Continuous Manufacturing,” Pharmaceutical Technology’s Quality and Regulatory Sourcebook eBook (March 2022).

Articles in this issue
Common FDA 483 Observations for Combination Products
Common FDA 483 Observations for Combination Products
Facilitating Biopharma Continuous Manufacturing
Facilitating Biopharma Continuous Manufacturing
Warut/Stock.adobe.com – Testing cleanroom garments while in use and during daily cleanroom operations is vital for contamination control.
In-Use Testing of Cleanroom Garments
How a Lack of Critical Thinking is Hindering Regulatory Compliance
How a Lack of Critical Thinking is Hindering Regulatory Compliance
A Method Validation Framework for Combination Products
A Method Validation Framework for Combination Products
Contextualizing Computer Validation
Contextualizing Computer Validation

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
Related Content
Titanium dioxide, E171, dangerous additive concept. gum, pills, toothpaste, powder and sign with E171 on yellow background. copy space banner | Image credit: ©Анна Мартьянова - stock.adobe.com
September 15th 2025

The Impact of Europe’s Decision on the Use of Titanium Dioxide

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
September 15th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Hand touching Telecommunication network and wireless mobile internet technology with 5G LTE data connection of global business, fintech, blockchain. | Image Credit: © greenbutterfly - © greenbutterfly - stock.adobe.com
September 15th 2025

PDA 2025: Strategic AI Adoption in Bio/Pharma Manufacturing

Feliza Mirasol
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail
September 15th 2025

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
Binary code and lock shape on pixellated screen | Image Credit: © JohanSwanepoel - © JohanSwanepoel - stock.adobe.com
September 15th 2025

PDA 2025: How Data-Driven AI Transforms Quality Control & Development

Feliza Mirasol
Woman using nasal drops | Image Credit: © Alliance - stock.adobe.com
September 15th 2025

Epinephrine Nasal Spray Comparable to Injection in Real-World Data of Patients Experiencing Anaphylaxis

Patrick Lavery
© 2025 MJH Life Sciences

All rights reserved.